Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02936323
Title PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tarveda Therapeutics
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Florida Cancer Specialists South Fort Myers Florida 33901 United States Details
Florida Cancer Specialists North Saint Petersburg Florida 33705 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Boston Medical Center Boston Massachusetts 02118 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center/ NY Presbyterian Manhattan New York 10032 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Sarah Cannon Research Institute/Tennessee Oncology Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University College London London United Kingdom Details
The Christie NHS Trust Manchester United Kingdom Details
Southampton General Hospital Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from for the field